Lei @ Sinotherapeutics Inc is a specialty pharma company founded in 2012, focusing on the R&D, registration, manufacture, and commercialization of complex generic products and innovative formulation products (505B2) within the biotechnology industry. The company's slogan emphasizes its dedication to providing cost-effective, high-quality products to international markets. Currently, specific details about the headquarter location and the latest investment, including investors and amounts, are not available. Sinotherapeutics' main goal is to achieve global commercialization of its products, indicating a strong ambition for international expansion and market penetration. The company's dedication to research and development, coupled with its focus on both traditional generics and innovative formulations, positions it as an intriguing player in the pharmaceutical industry.
There is no investment information
No recent news or press coverage available for Lei @ Sinotherapeutics Inc.